0 (0%) | 09-27 09:33 | |||||||||||||
|
|
Short term | ![]() |
|||
Mid term | ![]() |
|||
Targets | 6-month : | 24.22 ![]() |
1-year : | 24.74 |
Resists | First : | 20.74 ![]() |
Second : | 21.19 |
Pivot price | 20.75 ![]() |
|||
Supports | First : | 20.02 ![]() |
Second : | 16.65 ![]() |
MAs | MA(5) : | 20.47 | MA(20) : | 20.65 ![]() |
MA(100) : | 20.73 ![]() |
MA(250) : | 21.24 ![]() |
|
MACD | MACD : | 0.1 ![]() |
Signal : | 0.1 ![]() |
%K %D | K(14,3) : | 15.7 ![]() |
D(3) : | 24.7 ![]() |
RSI | RSI(14): 50.3 | |||
52-week | High : | 23.5 | Low : | 18.38 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ ARMR ] has closed above bottom band by 24.4%. Bollinger Bands are 24.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 20.53 - 20.63 | 20.63 - 20.71 |
Low: | 20.19 - 20.33 | 20.33 - 20.45 |
Close: | 20.28 - 20.5 | 20.5 - 20.67 |
Fri, 26 Sep 2025
AI and Biodefense – Working to Stay Ahead of Synthetic Drug Threats - CarbonCredits.com
Thu, 25 Sep 2025
Fentanyl – A National Security Crisis Demanding Prevention - CarbonCredits.com
Wed, 17 Sep 2025
ARMR Sciences – The Future of Drug Defense - CarbonCredits.com
Tue, 05 Aug 2025
ARMR Launches up to $30M Capital Raise - citybiz
Thu, 22 May 2025
PLAE Breaks New Ground With Plate-Loaded Strength Line - Athletech News
Thu, 10 Apr 2025
The BetaShares Global Defence ETF (ARMR) is up 19% this year. Are defence stocks the new safe haven? - MSN
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 0 (M) |
Shares Float | 0 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 0 (%) |
Shares Short | 0 (K) |
Shares Short P.Month | 0 (K) |
EPS | 0 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | 0 % |
Return on Equity (ttm) | 0 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | 0 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | 0 |
Price to Cash Flow | 0 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |